Registration for this session is additional to the congress registration fee and is €171 on site, €153 standard.
Aims : To present the innovations in asthma stratification that facilitate personalised therapeutic strategies. The specific aims are to highlight the importance of stratifying asthma patients for correct therapeutic approaches, explain the importance of both clinical and biomarker assesement in patient stratification, indicate the value of molecular stratification for understanding disease-driving mecanisms and hwo this may translate to nee therapies particularly for non-T2 asthma.
Target audience :
Allergologist, Clinician, Fellow, General practitioner, Immunologist, Junior member, Lung function technician, Occupational therapist, Pathologist, Pharmaceutical industry representative, Pulmonologist, Researcher, Resident, Respiratory physician, Scientist, Student, Trainee